Stock AnalizMorgan Stanley MS
Investment Bankers/Brokers/Service · data as of November 13, 2026
Morgan Stanley (MS) is a financial company listed in the US with a market value of about $298.4B. In the twelve months to September 30, 2026 it had revenue of $80.2B and net income of $19.8B, a net margin of 24.8%.
Its overall Stock Analiz score is 1.8 out of 5 (weak). The strongest part is shareholder returns (4/5); the weakest is financial health (0/5).
Key numbers: a P/E of 15.1, 5-year revenue growth of 8% a year. A discounted cash flow model with moderate assumptions puts its intrinsic value about 1% below the current price.
Score: 1.8 / 5
Checks passed
- P/E below 25
- Revenue growth above 10% last year
- Profit margin improving
- Profitable 5 years in a row
- ROE above 15%
- Pays a dividend
- Share count down over 3 years (buybacks)
- Dividend 3 years in a row
Checks not passed
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $80.2B | $70.6B | $61.8B | $54.1B | $53.7B | $59.8B | $48.8B | $41.5B | $40.1B | $37.9B | $34.6B |
| Net income | $19.8B | $16.9B | $13.4B | $9.1B | $11.0B | $15.0B | $11.0B | $9.0B | $8.7B | $6.1B | $6.0B |
| Free cash flow | -$61.5B | -$20.8B | -$2.1B | -$36.9B | -$9.5B | $31.7B | -$26.7B | $38.9B | $5.4B | -$6.1B | $4.1B |
| EPS (diluted) | $12.60 | $10.21 | $7.95 | $5.18 | $6.15 | $8.03 | $6.46 | $5.19 | $4.73 | $3.07 | $2.92 |
| Net margin | 24.8% | 23.9% | 21.7% | 16.8% | 20.5% | 25.2% | 22.6% | 21.8% | 21.8% | 16.1% | 17.3% |
| ROIC | — | — | — | — | — | — | — | — | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 22 analysts is $211.50, 11% above the current price; targets range from $185.00 to $262.00; the consensus rating is “Buy”; expected EPS is $12.91 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Morgan Stanley’s P/E ratio?
About 15.1, based on the last twelve months of diluted earnings per share (forward P/E about 14.3).
Is Morgan Stanley stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 1% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Morgan Stanley pay a dividend?
Yes. The dividend yield is about 2.41%, and it has paid dividends for 10 years in our data.
Is Morgan Stanley a good stock to buy?
We do not give buy or sell advice. Morgan Stanley scores 1.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.